154
Views
30
CrossRef citations to date
0
Altmetric
Original Article

Interferon Treatment in Patients with Malignant Carcinoids

, , &
Pages 445-449 | Published online: 08 Jul 2009

Reference

  • Bengmark S, Jeppsson B, Nobin A. Arterial ligation and temporary dearterialization. Liver tumours, L H Blumgart. Churchill Livingstone, London 1987; 1219
  • Moertel C G, Hanley JA. Combination therapy trials in metastatic carcinoid tumours and the malignant carcinoid syndrome. Cancer Clin Trials 1979; 2: 327
  • Mårtensson H, Nobin A, Bengmark S, Lunderquist A, Owman T, Sandén G. Embolization of the liver in the management of metastatic carcinoid tumors. J Surg Oncol 1984; 27: 152
  • öberg K, Norheim I, Lind E, et al. Treatment of malignant carcinoid tumors with human leucocyte interferon. Long-term results. Cancer Treat Rep 1986; 170: 1297
  • Eriksson B, öberg K, Aim G, et al. Treatment of malignant endocrine pancreatic tumours with human leucocyte interferon. Cancer Treat Rep 1987; 71: 31
  • Eriksson B, Aim G, Lundquist G, et al. Treatment of malignant endocrine pancreatic tumours with human leucocyte interferon. Lancet 1986; 2: 1307
  • öberg K, Funa K, Aim G. Effects of leucocyte interferon on clinical symptoms and hormone levels in patients with midgut carcinoid tumors and carcinoid syndrome. N Engl J Med 1983; 309: 129
  • Nobin A, Karp W, Lunderquist A, Rosengren E, Sandén G, Sundler F. Localization of carcinoids and pheochromocytomas with vein catheterization and amine determination. Brain Res Bull 1982; 9: 781
  • Cantell K, Hirvonen S, Koistinen V. Partial purification of human leucocyte interferon on a large scale. Methods Enzymol 1981; 78: 499
  • von Wusson P, Freund M, Block B, Diedrich H, Poliwoda H, Deicker H. Clinical significance of anti-IFN α-antibody titres during interferon therapy. Lancet 1987; 2: 635
  • Lundblad D, Lundgren E. Block of glioma cell line in S by interferon. Int J Cancer 1981; 27: 749
  • Quesada J R, Gutterman JU. Interferon and cell growth regulation. Eur J Cancer Clin Oncol 1981; 24: 1213

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.